James Sawalla Guseh, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exercise | 4 | 2022 | 5251 | 0.680 |
Why?
|
Blood Proteins | 2 | 2020 | 1144 | 0.670 |
Why?
|
Chest Pain | 1 | 2022 | 1100 | 0.560 |
Why?
|
Embolism | 1 | 2015 | 388 | 0.440 |
Why?
|
Plaque, Atherosclerotic | 1 | 2022 | 1365 | 0.420 |
Why?
|
Athletes | 4 | 2022 | 1038 | 0.370 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6213 | 0.340 |
Why?
|
Coronary Vessels | 2 | 2022 | 2964 | 0.340 |
Why?
|
Proteomics | 1 | 2020 | 3244 | 0.320 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 731 | 0.290 |
Why?
|
Receptor, Notch1 | 1 | 2009 | 524 | 0.290 |
Why?
|
Truth Disclosure | 1 | 2009 | 439 | 0.270 |
Why?
|
Boidae | 1 | 2022 | 14 | 0.230 |
Why?
|
Cytokines | 1 | 2017 | 7189 | 0.230 |
Why?
|
Complement Factor D | 1 | 2019 | 66 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2019 | 46 | 0.190 |
Why?
|
Complement C3a | 1 | 2019 | 70 | 0.190 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2019 | 76 | 0.190 |
Why?
|
Soccer | 1 | 2021 | 120 | 0.190 |
Why?
|
Social Support | 1 | 2009 | 2119 | 0.180 |
Why?
|
Erythema Infectiosum | 1 | 2018 | 12 | 0.170 |
Why?
|
Physical Conditioning, Animal | 1 | 2022 | 377 | 0.170 |
Why?
|
Oxygen Consumption | 2 | 2022 | 1928 | 0.170 |
Why?
|
Physical Endurance | 1 | 2020 | 387 | 0.160 |
Why?
|
Internet | 1 | 2009 | 3074 | 0.150 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2018 | 145 | 0.150 |
Why?
|
Running | 1 | 2020 | 466 | 0.140 |
Why?
|
Ventricular Remodeling | 2 | 2021 | 1280 | 0.140 |
Why?
|
Physician-Patient Relations | 1 | 2009 | 3316 | 0.140 |
Why?
|
Muscle Development | 1 | 2017 | 308 | 0.140 |
Why?
|
Electrocardiography | 2 | 2021 | 6386 | 0.130 |
Why?
|
Aortic Diseases | 1 | 2020 | 725 | 0.130 |
Why?
|
Cardiomegaly | 1 | 2017 | 653 | 0.130 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11323 | 0.130 |
Why?
|
Echocardiography | 3 | 2021 | 5139 | 0.120 |
Why?
|
Ultrasonography, Interventional | 1 | 2022 | 1480 | 0.120 |
Why?
|
Lung | 2 | 2009 | 9706 | 0.120 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1312 | 0.110 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 1976 | 0.110 |
Why?
|
Aorta | 1 | 2020 | 2120 | 0.110 |
Why?
|
Insulin-Secreting Cells | 1 | 2019 | 976 | 0.110 |
Why?
|
Heart Ventricles | 2 | 2021 | 3851 | 0.100 |
Why?
|
Stroke Volume | 2 | 2021 | 4522 | 0.100 |
Why?
|
Genetic Loci | 1 | 2020 | 2587 | 0.100 |
Why?
|
STAT6 Transcription Factor | 1 | 2009 | 206 | 0.090 |
Why?
|
Anemia | 1 | 2018 | 1403 | 0.090 |
Why?
|
Metaplasia | 1 | 2009 | 314 | 0.090 |
Why?
|
Self Disclosure | 1 | 2009 | 263 | 0.090 |
Why?
|
Critical Illness | 1 | 2020 | 2496 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9641 | 0.080 |
Why?
|
Mucus | 1 | 2009 | 315 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3411 | 0.080 |
Why?
|
Interleukin-13 | 1 | 2009 | 365 | 0.080 |
Why?
|
Endoderm | 1 | 2008 | 179 | 0.080 |
Why?
|
Humans | 16 | 2022 | 708843 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2009 | 3690 | 0.070 |
Why?
|
Professional Competence | 1 | 2009 | 451 | 0.070 |
Why?
|
Mesoderm | 1 | 2008 | 728 | 0.070 |
Why?
|
Adult | 8 | 2022 | 211041 | 0.070 |
Why?
|
Blood Pressure | 1 | 2020 | 8528 | 0.060 |
Why?
|
Heart | 1 | 2017 | 4315 | 0.060 |
Why?
|
Wnt Proteins | 1 | 2008 | 727 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2015 | 4383 | 0.060 |
Why?
|
Trachea | 1 | 2009 | 1076 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3153 | 0.060 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3275 | 0.060 |
Why?
|
Physician's Role | 1 | 2009 | 982 | 0.060 |
Why?
|
Interpersonal Relations | 1 | 2009 | 1406 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 11738 | 0.050 |
Why?
|
Rodentia | 1 | 2022 | 231 | 0.050 |
Why?
|
Respiratory Rate | 1 | 2022 | 160 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2009 | 11718 | 0.050 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2022 | 240 | 0.050 |
Why?
|
Male | 8 | 2022 | 349524 | 0.050 |
Why?
|
Young Adult | 3 | 2021 | 55940 | 0.050 |
Why?
|
Glycoproteins | 1 | 2008 | 2309 | 0.050 |
Why?
|
Cell Dedifferentiation | 1 | 2019 | 138 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 517 | 0.040 |
Why?
|
Parvovirus B19, Human | 1 | 2018 | 37 | 0.040 |
Why?
|
Cell Lineage | 1 | 2008 | 2630 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12031 | 0.040 |
Why?
|
Physical Fitness | 1 | 2022 | 706 | 0.040 |
Why?
|
Female | 7 | 2021 | 375205 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2022 | 802 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 10857 | 0.040 |
Why?
|
Fetal Death | 1 | 2018 | 454 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3813 | 0.040 |
Why?
|
Models, Animal | 1 | 2022 | 2221 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4677 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1918 | 0.030 |
Why?
|
Viremia | 1 | 2018 | 728 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3593 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 14075 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58184 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1333 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 20170 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2018 | 882 | 0.030 |
Why?
|
Body Mass Index | 2 | 2020 | 12366 | 0.030 |
Why?
|
Prospective Studies | 3 | 2022 | 50597 | 0.030 |
Why?
|
Mice | 4 | 2019 | 80876 | 0.030 |
Why?
|
Pandemics | 2 | 2022 | 7089 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2019 | 1343 | 0.030 |
Why?
|
Animals | 5 | 2022 | 170486 | 0.020 |
Why?
|
Headache | 1 | 2018 | 1109 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2008 | 8072 | 0.020 |
Why?
|
Fever | 1 | 2018 | 1588 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4150 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 23020 | 0.020 |
Why?
|
Galactosides | 1 | 2008 | 52 | 0.020 |
Why?
|
Signal Transduction | 2 | 2009 | 23950 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3418 | 0.020 |
Why?
|
Claudins | 1 | 2008 | 108 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4261 | 0.020 |
Why?
|
Autocrine Communication | 1 | 2008 | 185 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2008 | 284 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2018 | 1999 | 0.020 |
Why?
|
Middle Aged | 4 | 2022 | 213752 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2019 | 3866 | 0.020 |
Why?
|
Crohn Disease | 1 | 2018 | 2277 | 0.020 |
Why?
|
Integrases | 1 | 2008 | 553 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10566 | 0.020 |
Why?
|
Insulin | 1 | 2019 | 6648 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13536 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1988 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2008 | 1712 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 3002 | 0.010 |
Why?
|
Epithelium | 1 | 2008 | 1740 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 16008 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2008 | 15274 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13274 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 11594 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 1632 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4941 | 0.010 |
Why?
|
Indoles | 1 | 2008 | 1857 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39038 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 41038 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 26832 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 69553 | 0.010 |
Why?
|
United States | 1 | 2021 | 67165 | 0.010 |
Why?
|
Genotype | 1 | 2008 | 12863 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 84718 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 71483 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10803 | 0.010 |
Why?
|